Clinical Trial Update: A Trial of Edaravone Dexborneol in Acute Ischemic Stroke With Active Malignancy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial exploring Edaravone Dexborneol for acute ischemic stroke in patients with active malignancy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Stroke

Drugs mentioned

• Edaravone Dexborneol

Snippet

Sponsor: Nanfang Hospital, Southern Medical University | Conditions: Ischemic Stroke, Acute, Active Malignancies | Phase 4 | Status: NOT_YET_RECRUITING